StonvexLoading…
StonvexStonvexStonvexCore line items from CAE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | C$4.71B | C$4.28B | C$4.01B | C$3.37B |
Operating Income | C$729.20M | C$-185.40M | C$466.00M | C$284.20M |
Net Income | C$415.00M | C$-296.30M | C$231.90M | C$150.00M |
EPS (Diluted) | C$1.27 | C$-1.02 | C$0.69 | C$0.45 |
Total Assets | C$11.21B | C$9.83B | C$10.44B | C$9.58B |
Total Liabilities | C$6.24B | C$5.53B | C$5.85B | C$5.49B |
Cash & Equivalents | C$293.70M | C$160.10M | C$217.60M | C$346.10M |
Free Cash Flow OCF − CapEx | C$540.30M | C$237.10M | C$139.60M | C$146.00M |
Shares Outstanding | Not available | Not available | Not available | Not available |